British Society for Medical Mycology

Registered charity 1190926 · accounts filings on the Charity Commission register · also known as BRITISH SOCIETY FOR MEDICAL MYCOLOGY CIO, BSMM · also registered in Scotland as SC050556 (OSCR)

The charity works to advance education and promote research in medical and veterinary mycology, and to disseminate research results for public benefit. The charity holds annual scientific meetings, sponsors conference speakers, provides grants for mycology training and for participation in conferences.

Causes: Education/training · The Advancement Of Health Or Saving Of Lives · website · Get email alerts

Latest income
£29k
Latest spending
£35k
Registered
2020
Accounts read
FY2025

Financial health, per its FY2025 accounts

The accounts state that the society returned to previous activity levels but faced a total income deficit of almost £13,000 in 2024 due to reduced subscriptions and meeting deficits. Despite this, the society maintained a net worth of £197,093, indicating sufficient reserves to continue operations without immediate financial distress.

Automated summary of the FY2025 accounts; the evidenced findings below carry the verbatim passages.

What the accounts disclose

Accounts independently examined (not a full audit). Discloses 4 of 6 completeness components.

Register events

Trustees · trustee networks

Trustee list from the Charity Commission register (current, not historical).

Operates in: Northern Ireland · Scotland · Throughout England And Wales

Income and spending

Financial year endIncomeSpending
31/08/2025£29k£35k
31/08/2024£13k£11k
31/08/2023£13k£5k
31/08/2022£31k£3k
31/08/2021£2k£686

Common questions

Is British Society for Medical Mycology financially healthy?

Per its FY2025 accounts: The accounts state that the society returned to previous activity levels but faced a total income deficit of almost £13,000 in 2024 due to reduced subscriptions and meeting deficits. Despite this, the society maintained a net worth of £197,093, indicating sufficient reserves to continue operations without immediate financial distress. Its FY2025 accounts were independently examined.